SNT
Click for more information
9.09% 2.4¢ syntara limited

News: PXS Boehringer Ingelheim initiates phase IIA study of compound acquired from Pharmaxis, page-9

  1. quattro1
    80 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    25/08/17
    17:03
    Post #: 26767983
    There are a number of arms to this trial, each taking approx 12-16 weeks with varying doses in each arm (hence the 9 month estimated completion date).

    The Fast Track designation they've received will basically open up the door for more frequent meetings / communication with the FDA.

    Another box ticked today. GLTA
    PXS Price at posting: 28.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
2.4¢ 		Change
0.002(9.09%) 		Mkt cap ! $28.65M
Open High Low Value Volume
2.2¢ 2.5¢ 2.2¢ $12.04K 509.9K

Buyers (Bids)

No. Vol. Price($)
1 82668 2.3¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 100000 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.